Pola Penggunaan Obat Mood Stabilizer Pada Pasien Bipolar di Rumah Sakit Jiwa Daerah Atma Husada Mahakam
DOI:
https://doi.org/10.25026/mpc.v10i1.368Keywords:
Bipolar, Mood Stabilzer, Patterns of drug useAbstract
Bipolar disorder is a chronic mood disorder characterized by episodes of mania or hypomania that occur alternately or mixed with depressive episodes. This study aims to determine the characteristics of bipolar patients and patterns of drug use inpatient and outpatient bipolar patients at Atma Husada Mahakam Hospital. The type of this research is non experimental (descriptive) and done retrospectively. Data are collected from medical record. Research subjects were 84 inpatients and 137 outpatients with bipolar disorder diagnosis. Data are analyzed by describing research's objects. The results were obtained from inpatient and outpatient data showing 63% and 60% female sex, showing 26-35 years (early adulthood), not working, not married, and high school level education. The most usage pattern of drugs is a combination of 2 and 3 drugs, namely 74.99% for inpatient care and 73.71% for outpatient treatment. The drugs most commonly used are mood stabilizers (valproate acid) and atypical antipsychotics (risperidone).
References
[2] Vieta, E. 2013. Managing Bipolar Disorder in Clinical Practice. 3 ed. London: Springer Healthcare.
[3] Wening MA, Made S. Tulus S. Pengaruh
terapi kognitif restrukturisasi terhadap penurunan skor depresi pada pasien gangguan jiwa. The Soedirman Journal of Nursing. 2010; 5(3).
[4] Zulqarnain, M. A. (2017). Pasien Gangguan Afektif Bipolar Provinsi Jawa Barat Pada Tahun 2014-2015.
[5] Syafwan, A. F., & Sedjahtera, K. (2020). Artikel Penelitian Gambaran Peningkatan Angka Kejadian Gangguan Afektif dengan Gejala Psikotik pada Pasien Rawat Inap di RSJ Prof. Dr. HB. Sa’anin Padang pada Tahun 2010-2011. 3(2), 106–109.
[6] Notoatmodjo, S. 2007. Promosi Kesehatan dan Ilmu Perilaku. Jakarta: Rineka Cipta.
[7] Sadock, B.J., Sadock, V.A., Ruiz P. 2015. Kaplan & Sadock’s Synopsis of Psychiatry Behavioral Sciencesm Clinical Psychiatry. 11th ed. Philadelphia: Lippincott Wolters Kluwer.
[8] Geller, B., et al. 2012. A Randomized Controlled Trial of Risperidone, Lithium, or Divalproex Sodium for Initial Treatment of Bipolar I Disorder, Manic or Mixed Phase, in Children and Adolescents. Arch Gen Psychiatry, 69(5): 515-528.
[9] Haas, M., et al. 2009. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo- controlled study. Bipolar Disorder, 11: 687-700.
[10] Khalimah, Siti. 2015. How Does BPJS Support Inparient Treatment of Bipolar Disosrder. Konferensi Nasional 2 Bipolar dan Gangguan Mood Lain.
[11] Espossi L., Sangiorgi D et al. (2014). Pharmaco-utilisation and Related Costs of Drugs Used to Treat Schizophrenia and Bipolar Disosder in Italy: The IBIS Study. BMC Psychiatry, 14:282.
[12] Klein C. (2012) Managing Psychiatric Polypharmacy. Netsmart’s commitment.
[13] Kulkarni J, Fillia S, Berk L, Filliak, Dodd S, de Castella A, Brnabic AJM, Lowry A, Kellin K, Montgomery W, Fitzgerald PB, Berket P. (2012). Treatment and Outcomes of An Austrilian Cohort of Outpatients with Bipolar 1 or Schizoaffective Disorder Over Twenty-Four Months. Implications for Clinical Practice. BMC Psychiatry.
